Increase in incidence of organ failure owing to growing
cases of chronic diseases, rise in ageing population, and increase in focus on
R&D is expected to propel the growth of the Singapore transplant diagnostics
market. Chronic diseases can lead to organ failure in patients, which could be
a significant target audience for Singapore transplant diagnostics procedures. However,
difficulties in human leukocyte antigen (HLA) sequencing and increasing
worldwide organ shortage can hamper the market growth.
Get
Detail Report https://www.alliedmarketresearch.com/transplant-diagnostics-market
The reagents & consumables segment accounted for the
maximum revenue generation in 2015, owing to the increased number of
diagnostics procedures pre and post organ transplantation. The instruments
& equipment segment is projected to grow at a CAGR of 9.1% and reach $76.3
million by 2022. Both the technologies, namely non molecular assay and
molecular assay hold significant position in the global transplant diagnostics
market. However, molecular assay technology segment is projected to grow at the
highest CAGR of 12.3%, due to highly accurate results provided by the modern
molecular assay technology.
With rise in number of kidney transplants, the segment is
set to report a high revenue in the future, with a CAGR of 9.8%, owing to
increased incidence of renal failure worldwide. Liver and heart transplants are
estimated to report a strong growth rate during the forecast duration, due to
increased awareness for organ donations and increase in incidence of liver and
heart failure.
Download Sample
Report: https://www.alliedmarketresearch.com/request-sample/1135
0 Comments